Effects of three immunosuppressive drug protocols on cadaver renal transplantation costs after 4 years of therapy.
Canafax
D M
DM
University of Minnesota, Minneapolis 55455.
Carleton
B C
BC
Matas
A J
AJ
Payne
W D
WD
Dunn
D L
DL
Sutherland
D E
DE
Najarian
J S
JS
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003365:Costs and Cost Analysis; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000628:therapy; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000191:economics*; D016030:Kidney Transplantation / Q000191:economics* / Q000276:immunology*; D007902:Length of Stay; D011241:Prednisone / Q000627:therapeutic use; D016019:Survival Analysis; D014481:United States
D000961:Antilymphocyte Serum; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone